Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: Effects on bone, uterus, and lipid profile

Menopause

Volumn 12, Issue 5, 2005, Pages 589-600

  Gallo, Daniela ^a   Zannoni, Gian Franco ^a   Apollonio, Patrizia ^a   Martinelli, Enrica ^a   Ferlini, Cristiano ^a   Passetti, Gianluigi ^b   Riva, Antonella ^c   Morazzoni, Paolo ^c   Bombardelli, Ezio ^c   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Analist Srl   (Italy)

^c INDENA S P A   (Italy)

Author keywords

Bone; Isoflavones; Menopause; Rat; Soy; Uterus

Indexed keywords

DEOXYPYRIDINOLINE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; HORMONE RECEPTOR; INTERLEUKIN 6; OSTEOCALCIN; PLANT EXTRACT; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TISSUE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; MENOPAUSAL SYNDROME; MENOPAUSE; NONHUMAN; OVARIECTOMY; RAT; RECEPTOR UPREGULATION; SOYBEAN; STANDARDIZATION; STROMA CELL;

AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; BONE DENSITY; BONE REMODELING; DOWN-REGULATION; EPITHELIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HYPERPLASIA; INTERLEUKIN-6; ISOFLAVONES; LIPIDS; MENOPAUSE; MODELS, ANIMAL; ORGAN SIZE; OSTEOCALCIN; OVARIECTOMY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROGESTERONE; SOYBEANS; STROMAL CELLS; UP-REGULATION; UTERUS;

EID: 25444482167     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GME.0000156348.61767.D5     Document Type: Article

References (46)

1. Wuttke W, Jarry H, Westphalen S, Christoffel V, Seidlova-Wuttke DJ. Phytoestrogens for hormone replacement therapy? Steroid Biochem Mol Biol 2002;83:133-147.
2. Benassayag C, Perrot-Applanat M, Ferre F. Phytoestrogens as modulators of steroid action in target cells. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:233-248.
3. Setchell KDR, Brown NM, Desai P, et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavones supplements. J Nutr 2001;131:1362S-1375S.
4. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a standardized soy extract in postmenopausal women: a pilot study. Menopause 2000;7:105-111.
5. Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA. Vasomotor symptom relief by soy isoflavone extract tablets in post-menopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000;7:236-242.
6. [Published erratum appears in Menopause 2000;7:422.]
7. Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 2003;10:196-202.
8. Keenan MJ, Hegsted M, Jones KL, et al. Comparison of bone density measurement techniques: DXA and Archimedes' principle. J Bone Miner Res 1997;12:1903-1907.
9. Supko JG, Phillips LR. High-performance liquid chromatographic assay for genistein in biological fluids. J Chrom Biomed App 1995;66:157-167.
10. Snijders MP, de Goeij AF, Debets-Te Baerts MJ, Rousch MJ, Koudstaal J, Bosman FT. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil 1992;94:363-371.
11. Kalu DN. The ovariectomized rat model of postmenopausal bone loss [review]. Bone Miner 1991;15:175-191.
12. Wronski TJ, Cintron M, Doherty AL, Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 1988;123:681-686.
13. Qu Q, Zheng H, Dahllund J, et al. Selective estrogenic effects of a novel triphenylethylene compound, FC1271a, on bone, cholesterol level, and reproductive tissues in intact and ovariectomized rats. Endocrinology 2000;141:809-820.
14. Setchell KD, Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies [review]. Am J Clin Nutr 2003;78(3 Suppl):593S-609S.
15. Picherit C, Bennetau-Pelissero C, Chanteranne B, et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J Nutr 2001;131:723-728.
16. Arjmandi BH. The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency [review]. J Am Coll Nutr 2001;20(5 Suppl):398S-402S.
17. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;3;257:88-91.
18. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-1196.
19. Chen XW, Garner SC, Anderson JJ. Isoflavones regulate interleukin-6 and osteoprotegerin synthesis during osteoblast cell differentiation via an estrogen-receptor-dependent pathway. Biochem Biophys Res Commun 2002;295:417-422.
20. Jenkins DJ, Kendall CW, Connelly PW, et al. Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism. 2002;51:919-924.
21. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997;82:4196-4200.
22. Wronski TJ, Schenck PA, Cintron M, Walsh CC. Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 1987;40:155-159.
23. Burguera B, Hofbauer LC, Thomas T, et al. Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 2001;142:3546-3553.
24. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations ofphyto-oestrogens in Japanese men. Lancet 1993;342:1209-1210.
25. Morton MS, Arisaka O, Miyake N, Morgan LD, Evans BA. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 2002;132:3168-3171.
26. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 2002;13:200-204.
27. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones [review]. J Nutr 2002;32:3577-3584.
28. Wang H, Masironi B, Eriksson H, Sahlin L. A comparative study of estrogen receptors alpha and beta in the rat uterus. Biol Reprod 1999;61:955-964.
29. Nephew KP, Long X, Osborne E, Burke KA, Ahluwalia A, Bigsby RM. Effect of estradiol on estrogen receptor expression in rat uterine cell types. Biol Reprod 2000;62:168-177.
30. Cooke PS, Buchanan DL, Lubahn DB, Cunha GR. Mechanism of estrogen action: lessons from the estrogen receptor-alpha knockout mouse. Biol Reprod 1998;59:470-475.
31. Weihua Z, Saji S, Makinen S, et al. Estrogen receptor (ER) beta, a modulator of ER-alpha in the uterus. Proc Natl Acad Sci USA 2000;23;97:5936- 5941.
32. Pillai SB, Jones JM, Koos RD. Treatment of rats with 17β-estradiol or relaxin rapidly inhibits uterine estrogen receptor β1 and β2 messenger ribonucleic acid levels. Biol Reprod 2002;67:1919-1926.
33. Parczyk K, Madjno R, Michna H, Nishino Y, Schneider MR. Progesterone receptor repression by estrogens in rat uterine epithelial cells. J Steroid Biochem Mol Biol 1997;63:309-316.
34. Tibbetts TA, Mendoza-Meneses M, O'Malley BW, Conneely OM. Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. Biol Reprod 1998;59:1143-1152.
35. Kurita T, Lee KJ, Cooke PS, Taylor JA, Lubahn DB, Cunha GR. Paracrine regulation of epithelial progesterone receptor by estradiol in the mouse female reproductive tract. Biol Reprod 2000;62:821-830.
36. [Published erratum appears in Biol Reprod 2000;63:354.]
37. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS Jr. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-340.
38. Okulicz WC, Savasta AM, Hoberg LM, Longcope C. Immunofluorescent analysis of estrogen induction of progesterone receptor in the rhesus uterus. Endocrinology 1989;125:930-934.
39. Li W, Boomsma RA, Verhage HG. Immunocytochemical analysis of estrogen and progestin receptors in uteri of steroid-treated and pregnant cats. Biol Reprod 1992;47:1073-1081.
40. Dhaliwal GK, England GC, Noakes DE. Immunocytochemical localization of oestrogen and progesterone receptors in the uterus of the normal bitch during oestrus and metoestrus. J Reprod Fertil Suppl 1997;51:167-176.
41. Ing NH, Tornesi MB. Estradiol up-regulates estrogen receptor and progesterone receptor gene expression in specific ovine uterine cells. Biol Reprod 1997;56:1205-1215.
42. Kurita T, Lee K, Saunders PT, et al. Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse. Biol Reprod 2001;64:272-283.
43. Nestel PJ, Yamashita T, Sasahara T, et al. Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 1997;17:3392-3398.
44. Simons LA., von Konigsmark M, Simons J, Celermajer DS. Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000;85:1297-1301.
45. Lundeen SG, Carver JM, McKean ML, Winneker RC. Characterization of the ovariectomized rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 1997;138:1552-1558.
46. Liu D, Bachmann KA. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats. J Pharmacol Exp Ther 1998;286:561-568.